Please use this identifier to cite or link to this item:
|Title:||Application of computational biology and artificial intelligence technologies in cancer precision drug discovery||Authors:||Nagarajan, Nagasundaram
Yapp, Edward K. Y.
Le, Nguyen Quoc Khanh
Abeer Mohammed Al-Subaie
|Keywords:||Humanities::General||Issue Date:||2019||Source:||Nagarajan, N., Yapp, E. K. Y., Le, N. Q. K., Kamaraj, B., Abeer Mohammed Al-Subaie, & Yeh, H.-Y. (2019). Application of computational biology and artificial intelligence technologies in cancer precision drug discovery. BioMed Research International, 2019, 1-15. doi:10.1155/2019/8427042||Journal:||BioMed Research International||Abstract:||Artificial intelligence (AI) proves to have enormous potential in many areas of healthcare including research and chemical discoveries. Using large amounts of aggregated data, the AI can discover and learn further transforming these data into "usable" knowledge. Being well aware of this, the world's leading pharmaceutical companies have already begun to use artificial intelligence to improve their research regarding new drugs. The goal is to exploit modern computational biology and machine learning systems to predict the molecular behaviour and the likelihood of getting a useful drug, thus saving time and money on unnecessary tests. Clinical studies, electronic medical records, high-resolution medical images, and genomic profiles can be used as resources to aid drug development. Pharmaceutical and medical researchers have extensive data sets that can be analyzed by strong AI systems. This review focused on how computational biology and artificial intelligence technologies can be implemented by integrating the knowledge of cancer drugs, drug resistance, next-generation sequencing, genetic variants, and structural biology in the cancer precision drug discovery.||URI:||https://hdl.handle.net/10356/143985||ISSN:||2314-6133||DOI:||10.1155/2019/8427042||Rights:||© 2019 Nagasundaram Nagarajan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.||Fulltext Permission:||open||Fulltext Availability:||With Fulltext|
|Appears in Collections:||SoH Journal Articles|
Files in This Item:
|Application of computational biology and artificial intelligence technologies in cancer precision drug discovery.pdf||572.8 kB||Adobe PDF|
Updated on Mar 10, 2021
Updated on Dec 5, 2021
Updated on Dec 5, 2021
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.